Efficacy of recombinant human interferon α-2b on experimental endometriosis
article
OA: closed
CC0
⤵ 13 in-corpus citations
AI-generated summary
This study investigated the efficacy of recombinant human interferon α-2b in an experimental model of endometriosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
ObjectiveTo investigate the efficacy of recombinant human interferon alpha-2b on endometriosis.Study designThe randomized, placebo-controlled, single-blind, experimental study was performed on 30 Wistar female rats in the Experimental Surgery Laboratory at Ondokuz Mayis University in Turkey. After the peritoneal implantation of endometrial tissue, rats were randomized to two equal intervention groups: (1) the control group and (2) the interferon group. Six weeks later, after implant volume was measured (volume-1) by performing a second laparotomy, interferon alpha-2b (100,000 IU subcutaneously per rat, three times at 48 h intervals) was administered to the interferon group, and saline solution (0.1 ml SC, once per week), to the control group, for 8 weeks. At the end of the treatment, a third laparotomy was performed to remeasure implant volumes (volume-2), and implants were totally excised for histopathologic examination. Volume-1 and volume-2 within the groups, as well as stromal and glandular tissues between the groups were compared.ResultsIn the interferon group, volume-2 was statistically significantly reduced compared with volume-1, whereas there was no significant volume change in the control group. In the interferon group, when compared with the control group, both stromal and glandular tissues had statistically significantly lessened.ConclusionsInterferon alpha-2b was seen to regress significantly both the size and the histological structure of endometriotic implants.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (24)
- Effect of interferon α-2b on endometrioma cells in vitro via openalex
- Endometriosis: abnormal endometrium and dysfunctional immune response via openalex
- Immunobiology of endometriosis via openalex
- Immunology and endometriosis via openalex
- Intraperitoneal and subcutaneous treatment of experimental endometriosis with recombinant human interferon- α-2b in a murine model via openalex
- Laparoscopic intraperitoneal injection of human interferon-α2b in the treatment of pelvic endometriosis: a new modality via openalex
- Pathogenesis of endometriosis via openalex
- Treating endometriosis as an autoimmune disease via openalex
- Use of intraperitoneal interferon α-2b therapy after conservative surgery for endometriosis and postoperative medical treatment with depot gonadotropin-releasing hormone analog: a randomized clinical trial via openalex
- W2416234271 via openalex
- W2731754074 via openalex
- W3144701148 via openalex
- W4235962914 via openalex
- W6601454149 via openalex
- doi:10.1007/978-1-4757-3889-6_17 via openalex
- W6712053101 via openalex
- W1531612230 via openalex
- W1570261213 via openalex
- W1994443458 via openalex
- W2017876899 via openalex
- W2076085848 via openalex
- W2079959298 via openalex
- W2111249011 via openalex
- W2394617087 via openalex
Cited by (14)
- Immunoregulation by type I interferons in the peritoneal cavity 2021
- Anti-inflammatory cytokines in endometriosis 2019
- Interferons: pathogenetic rationale for the treatment of external genital endometriosis and clinical efficacy 2019
- The Non-Ergot Derived Dopamine Agonist Quinagolide as an Anti-Endometriotic Agent 2016
- On-label and off-label drug use in the treatment of endometriosis 2015
- On-label and off-label drug use in the treatment of endometriosis 2015
- Endometriosis 2013
- Effect of vitamin <scp>C</scp> on the growth of experimentally induced endometriotic cysts 2013
- Effect of human interferon-alpha-2b on experimental endometriosis in rats: comparison between short and long series of treatment 2013
- Endometriosis: The Role of Neuroangiogenesis 2011
- Efficacy of anti-tumor necrosis factor therapy on endometriosis in an experimental rat model 2010
- Endometriosis 2009
- New drugs in development for the treatment of endometriosis 2008
- Emerging drugs for endometriosis 2008
Source provenance
- europepmc
- last seen: 2026-08-23T06:15:12.370321+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:14:48.452140+00:00
- unpaywall
- last seen: 2026-08-22T06:23:50.750314+00:00
License: CC0
· commercial use OK